Related Experiment Video
Updated: Mar 2, 2026

05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
769
Marijuana Use in Pregnancy: Concerns in an Evolving Era
Journal of Midwifery & Women'S Health
|May 13, 2017
Summary
Marijuana use during pregnancy is increasing and linked to adverse outcomes like lower birth weight and developmental issues. Experts advise against its use during pregnancy and breastfeeding due to potential risks.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Health
- Neurodevelopmental Pediatrics
Background:
- Marijuana is the most prevalent illicit drug used during pregnancy in the U.S.
- Increasing rates of marijuana consumption in pregnant individuals necessitate further investigation.
- Existing research is often limited by study design and confounding variables.
Purpose of the Study:
- To review the current evidence on the association between marijuana use during pregnancy and adverse neonatal and developmental outcomes.
- To synthesize findings regarding the presence of marijuana compounds in breast milk.
- To highlight recommendations from professional societies regarding marijuana use in pregnancy and lactation.
Main Methods:
- Literature review of existing studies on marijuana use in pregnancy.
- Analysis of data associating in utero marijuana exposure with birth outcomes.
- Examination of research on marijuana presence in breast milk.
Main Results:
- Associations found between prenatal marijuana exposure and decreased birth weight.
- Increased risk of spontaneous preterm birth identified with marijuana use in pregnancy.
- Evidence suggests impaired neurodevelopment in children exposed to marijuana in utero.
- Moderate concentrations of marijuana detected in breast milk.
Conclusions:
- Growing evidence links marijuana use during pregnancy to adverse outcomes.
- Marijuana compounds are present in breast milk, posing risks to nursing infants.
- Professional medical societies strongly recommend against marijuana use during pregnancy and lactation.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
864
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
864
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
1.3K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
1.3K
Hallucinogens and Psychedelics
825
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
825
Teratogenicity
4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Factors Affecting Drug Response: Overview
3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K

